HIGHLIGHTS
- What: The authors provide a comprehensive overview of both inter- and intratumoral heterogeneity in target antigen expression in pediatric AML and identify preexisting antigen-negative or low subpopulations prone to antigen escape. The authors evaluated a cohort of primary pediatric AML samples by multicolor flow cytometry to define the landscape of potential target antigens. The authors demonstrate as a proof-of-concept that the AdCAR platform can be easily adapted to meet these requirements. Selected antigens in this study have been intensively investigated in AML in the context of monoclonal_antibodies , antibody‒drug conjugates , bispecific antibodies and CAR . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.